Emergency Medicine Doctors in Big Bear Lake, CA Accepting Medicare
8 Emergency Medicine doctors found. Showing 1 - 8
 Brent Alan Beaird, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 41870 Garstin Dr, Big Bear Lake, CA 92315 Phone: 909-866-6501 |
Dr. Donald R. Hoechlin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 41870 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8201 Fax: 909-878-8286 |
Dr. Michael P. Hartstein, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 41870 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8201 Fax: 909-878-8286 |
 Dr. Sara L. Kossuth, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 41870 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8201 Fax: 909-878-8286 |
Norman Eric Johnson, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 41949 Big Bear Blvd, Big Bear Lake, CA 92315 Phone: 909-878-3696 Fax: 909-878-3697 |
Dr. Christopher H. Fagan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 41945 Big Bear Blvd Ste 200, Big Bear Lake, CA 92315 Phone: 909-866-5868 |
Dr. Peter S. Boss, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 41870 Garstin Drive, Big Bear Lake, CA 92315 Phone: 909-878-8201 Fax: 909-878-8286 |
Dr. Edward T Perry Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 41870 Garstin Dr, Big Bear Lake, CA 92315 Phone: 909-866-6501 |
News Archive
Delays and variability in UK clinical research projects result in skill shortages
Significant new research from Warwick Business School and Queen Mary, University of London, warns that delays and variability in the approvals process for clinical research could be causing pharmaceutical companies to look outside the UK and risks the country losing some of its most experienced researchers.
Nutra Pharma to market its OTC pain reliever in Brazil and Colombia, begins the drug registration process
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.
First Edition: July 9, 2013
Today's early morning highlights from the major news organizations, including a look at HHS Secretary Kathleen Sebelius' challenges and a delay in implementing insurance penalties on smokers.
FDA approval for Diovan (Valsartan)
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.
Novel mouse model can help monitor kidney disease progression and perform drug screening
Chronic kidney disease affects 750 million people each year. Aging populations and an increase in diseases such as diabetes will lead to a greater burden of kidney disease.
› Verified 8 days ago
Emergency Medicine
Family Medicine
General Practice
Psychiatry & Neurology